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Vascular Permeability and Neurotoxicity
by Jean M. Jacobs*
Neurotoxic substances affect the nervous system in a selective manner. One possible basis for this
selectivity is blood vessel permeability. In general, the central nervous system and the peripheral nerve
trunks have impermeable blood vessels, but in certain parts the capillaries are "leaky," allowing the
passage of a plasma filtrate. Intravenously injected protein tracers rapidly reach nerve cells in these
regions, with the implication that these nerve cells are also readily accessible to circulating neurotoxic
substances.
Some examples of neurotoxicity in the central nervous system show a selectivity that could be due to
capillary permeability. In experimental methylmercury poisoning, cranial nerve V and sensory dorsal
root ganglia, which lie in regions ofvascular permeability, are particularly susceptible. A numberofdrug
and chemically induced neuropathies are predominantly sensory, and may be due, directly or indirectly,
to the accessibility of neurotoxic substances to sensory neurons.
Examination of areas of potential vulnerability to circulating toxic substances may be of value in the
experimental testing of substances for neurotoxicity, where pharmacological tests may be negative and
clinical symptoms difficult to assess.
Neurotoxic substances characteristically produce
effects that are selective to particular parts of the
nervous system, resulting in identifiable patterns of
neuropathological changes.
This selectivity is often difficult to explain and
many factors may be involved. A better under-
standing of these factors, and the ability to recog-
nize those components ofthe nervous system which
may be particularly vulnerable, could be useful in
the assessment of potential neurotoxicity.
One purpose ofthis paper is to suggest how vas-
cular permeability might play a role in determining
this selectivity; other factors that may account for
the vulnerability of particular parts of the nervous
system are also discussed.
Nerve Cell Organization
All nerve cells have a similarbasic organization; a
cell body or perikaryon and one or more processes
ofvariable length, the longest extending for perhaps
a metre or more. Most of the synthetic activity of
nerve cells takes place in the perikaryon, and many
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substances essential for the maintenance ofthe pro-
cesses or axons must be transported along their
length. Some nerve cells such as the lumbar sensory
ganglion cells, giving off a peripheral process ex-
tending down the hind limb, and a central fiber run-
ning the length of the spinal cord, must support a
very large volume ofaxoplasm; indeed, it has been
calculated that such cells must synthesize several
times their own volume of perikaryal cytoplasm
every 24 hr.
The axon, therefore, is very dependent upon its
parent cell body. If an axon is cut or crushed, that
part no longer in continuity with the perikaryon will
degenerate. Axonal degeneration may follow, not
only from loss of physical continuity with its cell
body, but also as a consequence oftoxic damage to
the perikaryon or to transport mechanisms along
the axon, or, possibly a direct effect of the toxin
upon the axon. A result of this metabolic depen-
dence of the axon upon the nerve cell body is that
structural parameters of nerve cells such as the
length and diameter oftheir axons can be important
factors in determining patterns of nervous system
damage. This is exemplified in the distal type of
nerve fiber degeneration produced in a number of
toxic neuropathies, which tends to occur in the
largest and longest nerve fibers, and which has been
recently reviewed by Spencer and Schaumburg (1).
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Barriers
Morphology
Capillaries in brain and somatic and autonomic
peripheral nerves differ from those in other tissues.
Their component endothelial cells are closely con-
nected by tight junctions; also, there is little evi-
dence of any significant vesicular transport across
these cells. Vascular endothelial cells in nonner-
vous tissues contain an actomyosinlike protein
which responds to released histamine, causing cel-
lular contraction and separation one from another.
Cerebral endothelial cells do not appear to have this
contractile protein, and do not respond to histamine
in this way. These features, which restrict the
movement of substances between blood and brain
or nerve, form the morphological basis of the
blood-brain and blood-nerve barriers. Table 1
shows some characteristics of nervous system
capillaries compared with those in other tissues (2).
The term "barrier" is a misleading one in this
context because there is clearly movement of some
substances from the blood into the brain. Rapoport
(2) has suggested that cerebral and nerve capillaries
act more as a "regulatory interface."
Factors Affecting the Passage of Substances
at Blood-Brain and Blood-Nerve Barriers
The narrow cleft that separates the endothelial
cells at tightjunctions imposes physical limits to the
intercellular passage of molecules, limits which are
further modified by the presence of negatively
charged material within the gap. The restriction of
protein molecule exchange at the blood-brain bar-
rier is recognized as an important protective
mechanism. There is restricted transendothelial
passage of ions and lipid-insoluble nonelectrolytes,
but specific mechanisms exist for the rapid transfer
of certain aminoacids and monosaccharides impor-
tant inbrain metabolism. Ofpractical significance is
the fact that potentially useful drugs may not enter
the brain because they are either too ionized or are
not lipid-soluble.
Regions of the Brain Lacking a Blood
Barrier
The nervous system in this way may be protected
to some extent from circulating toxic substances.
Certain regions, however, have no blood-brain bar-
rier; their capillaries have slits or fenestrations al-
lowing rapid exchange of a plasma filtrate through
these extremely attenuated regions of the endothe-
lial cell. This feature carries with it the implication
that toxic substances, too, may pass readily be-
tween blood and nervous tissue.
Central Nervous System. Certain small areas
of the brain contain cells which produce hormones
or act as hormonal or chemoreceptors, functions
requiring a close association with blood. Such areas
include the circumventricular organs such as the
median eminence, neurohypophysis and sub-
fornical organ, and the area postrema. Using
methods involving the intravenous injection oftrac-
ers, in particular a hemeprotein, horseradish
peroxidase, (HRP) the sites and extent of vascular.
permeability can be observed by light and electron
microscopy (4). This technique can also demon-
strate that the tracer, having passed through perme-
Table 1. Classification ofcapillaries according to type of endothelium.a
Type of Basement Contractile Vesicular
endothelium membrane Endothelial connections protein transport Tissue distribution
Continuous Continuous Continuous belts tight Absent Rare Brain, endoneurium
junctions with cell (peripheral nerve)
separation of 12 A
Continuous Continuous Spotjunctions and clefts Present Very common Skeletal muscle,
between cells 100 A wide heart, dermis
Fenestrated Discontinuous Fenestrae in cells, ? Minimal Endocrine glands,







Discontinuous Discontinuous Intercellular gaps 0.1 Present Liver, bone marrow,
(sinusoidal) or absent to 1 ,um wide spleen
a Adapted from Majno (3), Karnovsky (4, 5) and Rapoport (2).
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endings and transported in a retrograde direction
back to the parent cell body.
Although there are few relevant examples, it is
tempting to speculate that some selective toxic ef-
fects in the central nervous system (CNS) may be
explained by such mechanism. Monosodium gluta-
mate produces damage experimentally to parts of
the central nervous system, which closely corre-
spond to sites lacking a blood-brain barrier (6), and
a number of its analogs also produce neuronal de-
. ~~~~~~~ .1
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FIGURE 1. Sections through the hypothalamic region of mouse
brain showing the arcuate nucleus (A), median eminence
(ME) and third ventricle (III): (a) Normal 10-day-old mouse,
x 280; (b) 10-day-old mouse, 6 hr after an 18 mmole/kg SC
dose of monosodium glutamate; neurons in the arcuate nuc-
leus have swollen cytoplasm and pyknotic nuclei, x 280; (c)
dark-field micrograph showing peroxidase-labeled cells in the
arcuate nucleus and in the median eminence in a mouse given
_ R .{ { HRP 24 hr before killing. Figs. la and lb reproduced by
__.S w . 2\-t5courtesy of J. W. Olney; Fig. Ic reproduced by courtesy of
M. W. Brightman.
. :t . generation of the arcuate nucleus of the
g2- ,>ffi >*v_. :. \
- phypothalamus (Fig. 1) (7). Tracer experiments (8)
+ te v..vw$/ tjx *, *~. ->have shown that the arcuate nucleus is in a region of - W vascular permeability, and also that the axons of
.:tv*e- , '-*~~. ' t:*9 nerve cells in this nucleus enter a region of perme-
*'&;svi ;bo%¢¢+af^X;4j:..'; ; - able capillaries, possibly the median eminence. .'v' Tracer appears to be taken up by these axons and
V?f*5strmw s*+'<<...... <, ^, ^,s,,transported back to nerve cell bodies in the arcuate
&*g ... bv%*;e)*. :CW' ;~*'f.8b-Stnucleus (Fig. 1). Other studies (9) have shown that
- @ 4 4i$&*<* glutamate can be taken up and transported along an
_ axon in aretrograde direction. A similar route could
be taken by glutamate that has leaked across capil-
laries of the median eminence. Aspartame, a syn-
thetic sweetener, was found, when fed to mice, to
(b) produce lesions in the arcuate nucleus similar to
October 1978 109those produced by monosodium glutamate (10). As-
partame is a dipeptide which is broken down in the
gut into phenylalanine and aspartate, the latter
aminoacid probably being the toxic agent. A recent
report (11) has also shown that L-alanosine, a new
antileukemic agent, also produces acute necrosis of
the arcuate nucleus, as well as of the subfornical
organ and the area postrema, which are both areas
of vascular permeability.
Peripheral Nervous System. Impermeable
capillaries are present within somatic and au-
tonomic peripheral nerve trunks, but tracer studies
have shown (12-17) that blood vessels in dorsal root
ganglia are permeable. Figure 2 shows a 1 ,um sec-
tion ofa dorsal root ganglion in a rat intravenously
injected 2 min before killing with the tracer HRP.
This is seen as a dark reaction product lying be-
tween ganglion cells. Electron microscope studies
have shown (17) that, within 5 min of injection of
HRP, the tracer is found lying between the satellite
cells and adjacent to ganglion cells and their axons
(Fig. 3). Some ganglion capillaries were found to be
fenestrated (Fig. 4). Even in an animal not injected
with tracer it is possible to see proteinaceous ma-
terial lying between the ganglion cells.
A recent study has also shown tracer leakage in
autonomic sympathetic ganglia, fenestrated blood
vessels being more numerous here than in dorsal
root ganglia. Although it has been stated (18) that
the perikaryal ganglion cell surface does not come
into direct contact with the extracellular space
proper but only with the inner surface of the satel-
lite cells, tracer studies have demonstrated that
materials in the extracellular space can penetrate to
the ganglion cell surface (19).
Other Parts ofthe Nervous System Exposed to
a Plasma Filtrate. The myenteric plexus is an
extensive network ofgroups ofnerve cells and con-
FIGURE 2. Section (I gm) ofa rat dorsal root ganglion 2 min after
intravenous HRP. Peroxidase appears as black reaction
product lying in the extracellular spaces, outlining the gan-
glion cells. x 1235.
necting nerve cells processes lying between muscle
layers along the whole length ofthe gastro-intestinal
tract. No blood vessels are present in the myenteric
plexus, but HRP penetrates freely into the plexus,
having leaked out of blood vessels in the adjacent
muscle layers (19). This represents a considerable
volume of nervous tissue potentially exposed to a
plasma filtrate.
Some leakage ofan intravenous tracer was found
in the optic nerve due to imperfections in the
meninges or membranes covering the optic nerve
where they fuse with the sclera or outer coat ofthe
eye (20); tracer diffusion into the optic nerve was
confirmed more recently in an electron microscope
study (21).
The axonal endings ofa muscle nerve are covered
only by basement membrane. Tracers such as HRP
can pass readily across muscle capillaries and dif-
fuse into the gap between axon and muscle, the
myoneural junction. There it may be taken up by
axonal endings and transported in a retrograde di-
rection back to the cell body in the spinal cord or
brain (8, 22). Sensory endings can also take up
tracer for transport back to the parent cell body (8,
22).
Examples in Which Vascular
Permeability May Determine
Patterns of Neurotoxic Changes
The ideathatthe distribution ofdamage produced
by neurotoxic substances might in some cases be
influenced by blood vessel permeability arose dur-
ing experimental studies of methylmercury poison-
ing (23-25). The effects of methylmercury upon
nervous tissue are associated with a disturbance to
protein synthesis. In vitro (26) and in vivo (27)
studies had shown impairment ofthe incorporation
of labeled amino acids into protein, and ultra-
structurally, methylmercury appeared to have a di-
rect effect upon ribosomes in nerve cells (23-25)
(Fig. 5). Loss ofthe protein synthesizing capability
ofthe nerve cell may lead to its death; alternatively,
damage to the nerve cell may not be lethal, so that
the perikaryon survives, although its axon degener-
ates.
Dorsal root and nerve V ganglia were found to be
particularly affected in experimental studies in rats
(23, 24, 28-30), rabbits (25, 31), pigs (32), and mon-
keys (28). Degeneration ofnerve cells in autonomic
ganglia and their associated nerves (Fig. 6) and in
the myenteric plexus has been seen in rats poisoned
with methylmercury (Jacobs 1977, unpublished). In
all these experimental situations, relatively large
doses were given, producing high blood levels of
Environmental Health Perspectives.,. .. .r := = < * *w,. ...
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FIGURE 3. Lumbarganglion from a rat 5 min afterintravenous HRP, showing peroxidase in the extracellular space: (a) low power view,
x 6750; (b) higher power showing HRP between the satellite cell processes and in the perineuronal space (single arrow) and
periaxonal space (double arrow), x 26,000.
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4l:FIGURE 4. Blood vessel from lumbar ganglion of a rat, showing numerous fenestrations (arrows): (a) x 10,000; (b) x 28,000.
mercury which presumably could rapidly reach the
ganglion cells because of the permeability of the
ganglionic blood vessels. In studies of a more
chronic type on monkeys (33, 34), lower blood
levels ofmethylmercury are produced, and ganglion
cells are less dramatically affected, a situation
probably paralleling that in humans. Nevertheless,
in Minamata disease, there is some evidence of
damage to peripheral sensory and autonomic nerves
(35, 36). Dorsal root ganglia were affected in a child
accidentally given intravenous methylmercury
(Takeuchi, 1976 unpublished).
Methylmercury is highly lipid-soluble and un-
doubtedly can cross the blood-brain barrier, but its
rapid and markedly selective effect upon ganglion
cells may be a reflection ofthe ease with which it is
able to reach these cells.
A number of other drugs, industrial agents, and
metals appear to produce a predominantly, or
purely sensory neuropathy. In almost every case,
sensory symptoms are the first to appear, even if
the neuropathy progresses to involve motornerves.
Chloramphenicol (37), chlorobiphenyl (38),
chlorodinitrobenzene (39), dinitrobenzene (39),
clioquinol (37, 40), disulfiram (37), nitrofurantoin
(37), and thalidomide (37, 40) produce a predomi-
nantly sensory neuropathy in man. Acute arsenic
intoxication in humans results in a sensory
neuropathy (41); thallium in the cat produces a sen-
sory neuropathy, but with sparing of muscle sen-
sory nerve fibers (42). A recent study (43) has de-
scribed neuronal abnormalities in lumbar and
trigeminal sensory neurons with concomitant de-
generation ofthe associated peripheral nerves, dor-
sal roots and dorsal columns of the spinal cord, in
rats given a single intravenous dose of adriamycin,
Environmental Health Perspectives 112an anthracycline antibiotic which inhibits cellular
DNA and RNA synthesis.
In view ofthe observation that there are deficien-
cies in the barriers to vascular permeability in the
optic nerve, it is interesting to note that some
neurotoxic substances, e.g., clioquinol, chloram-
phenicol, chlorodinitrobenzene, and dinitrobenzene
affect the optic nerve as well as the sensory gan-
glion cells. There is a paucity of information re-
garding the nature of these optic nerve lesions, so
FIGURE 5. Part of a ganglion cell (a) from the cervical ganglion of a control animal, showing the normal arrangement of organelles,
x 17,500; (b) from the cervical ganglion ofa rabbit given 2 doses of7.5 mg/kg ofmethylmercury acetate, by mouth. There is loss of
roughendoplasmic reticulum (RER); afew strands ofdegranulated RERare seen, but otherwise only granular material remains, and
an occasional mitochondrion which appears normal; x 17,500.
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FIGURE 6. Celiac ganglion from a rat given 8 doses of7.5 mg/kg methylmercury acetate by mouth: (a) one ganglion cell is degenerating
(asterisk) and contains many small vacuoles, x 6500; (b) numerous degenerating unmyelinated nerve fibers are seen, x 13,000.
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not clear. Autonomic ganglia and the myenteric
plexus are rarely, if ever, examined in studies of
neurotoxicity. Nerve damage due to the entry of
toxic substances from sensory and muscle nerve
endings has not been widely investigated, although
the importance of this route in viral disease is rec-
ognized (22). The unique fmding, in thallium intox-
icated rats, of sensory denervation in all regions
other than muscle suggested to Cavanagh (42) that
thallium may enter from sensory endings except
those in muscle, where a large pool of K+ ions
perhaps restricts its entry.
Exposure ofnerve cells to neurotoxic substances
may not produce morphological changes in those
cells, even though their metabolism may be af-
fected; however axonal degeneration may occur. In
some distal axonal degenerations, neuronal
perikarya are reported as being unaffected, al-
though good experimental evidence is often lacking
and closer study may reveal changes. Atlater stages
ofintoxication, dorsal root ganglion cells may show
chromatolytic changes, indicating previous damage
to these cells with subsequent recovery and regen-
eration of the axons.
Clinical symptoms may be difficult to recognize
in animals; the endocrine deficiency produced by
monosodium glutamate, forexample, would have to
be specifically sought; sensory neuropathy may also
be difficult to detect.
Neuropharmacological tests may be negative in
animals with severely degenerated nerves (44). In
most cases ofhuman neuropathies caused by drugs,
animal screening experiments had failed to show
that the drugs were neurotoxic (37). An awareness
of the accessibility of particular nerve cells or pro-
cesses to circulating substances may suggest new
ways of assessing neurotoxicity.
I would like to express my indebtedness to Professor J. B.
Cavanagh for the help and guidance he has given me in much of
the experimental work referred to in this paper.
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